Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

NCT01815450 is registered in ClinicalTrials.gov with Braintree Laboratories as lead sponsor.

NCT NCT01815450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01815450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
Lead sponsor
Braintree Laboratories
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2013
Completion date
Not reported
Enrollment
369 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris